Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... Findings May Potentially Lead to New Approach to stroke Treatment BOCA RATON, Fla., July 30 ... vessel) therapy made its debut two decades ago, stroke care underwent a major shift as the "window of treatment" for patients suffering a stroke was expanded to eight hours within symptom onset, ...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... test for gauging individual risk of AF and stroke and helping to identify stroke patients who may benefit from enhanced monitoring ... 20% greater risk of AF and cardioembolic stroke than are individuals who carry none. AF is the ...

CoAxia, Inc. Announces $21.5M Series D Financing

... studies of its NeuroFlo catheter in additional stroke patient populations; a) those treated as late as 24 hours after stroke onset, and b) those who received NeuroFlo ... with intravenous tPA - the only FDA approved stroke treatment. If the trials are successful, CoAxia ...

New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring

... Does the Pleth Variability Index correlate with stroke volume variation? Researchers in the Department ... the accuracy of Masimo PVI measurements with stroke Volume Variation (SVV) obtained via an invasive ... Does the Pleth Variability Index correlate with stroke volume variation?. Eur J Anaesthesiol 2009 ; 26 ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... from heart attack (7 versus 10) and fewer from stroke (0 versus 5) Fewer events of a ... includes cardiovascular death, heart attack or stroke (154 events or 6.9 percent versus 165 events or ... failure, or for prevention of heart disease or stroke Take insulin or nitrate medicines ...

New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug

... pump inhibitors raise risk of heart attack and stroke for patients taking Plavix(R) and increase ... Care and Outcomes Research in Cardiovascular and stroke (QCOR). "Our study, along with a 2007 FDA ... in reducing the risk of death, heart attack and stroke after coronary stenting, patients and their ...

D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients

... III clinical trial of DP-b99 in acute ischemic stroke patients. D-Pharm plans to initiate the trial ... enroll 770 moderate to severely affected ischemic stroke patients in over 100 clinical sites in North ... an array of brain damaging processes occurring in stroke patients and emerged from D-Pharm's proprietary ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... risk of cardiovascular death, heart attack or stroke compared with those patients who had normal ... endpoint of cardiovascular death, heart attack or stroke was 8.5 percent (N=407) in those who carried at ... of cardiovascular death, heart attack, or stroke by 19 percent (9.9 percent versus 12.1 percent), ...

Statins Lower Stroke Severity, Improve Recovery

... that patients who were taking statins before a stroke experienced better outcomes and recovery than ... reported in the current issue of the Journal of stroke and Cerebrovascular Diseases . "We were ... the daily use of statins had more of an impact on stroke patients than simply lowering their "bad" ...

Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis

... to the state's economy. The 312 heart and stroke medicines now being developed, more than double ... in 2005. Innovative potential heart and stroke medicines - five being developed here in Indiana ... to Hoosiers because cardiovascular disease and stroke are the leading causes of death in the state. ...

Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009

... laser therapy (TLT) for acute ischemic stroke within 24 hours of stroke onset demonstrated improved outcomes for ... at the American Heart Association's International stroke Conference in San Diego, CA by Justin Zivin, ...

Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet

... whole grains and fish -- are at a lower risk for stroke and coronary heart disease, according to a study ... in heart disease risk, and a 13% reduction in stroke risk when compared with those women whose diets ... of the heart (coronary heart disease) and stroke are two of the top three leading causes of death ...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

... is a complex disease that increases the risk of stroke up to five-fold(3), worsens the prognosis of ... cardiovascular disease. AF increases the risk of stroke up to five-fold and heart failure ... AF can lead to serious complications such as stroke and congestive heart failure. In addition to ...

AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi

... Medical Corporation today launched a web-based stroke education and awareness program featuring Tedy ... a professional football player who suffered a stroke in February 2005, subsequently recovered and ... that describe Tedy's firsthand experience as a stroke victim, survivor and prevention champion. "I ...

Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research

... -- Stents can be placed in the brain to treat a stroke as it's occurring, suggests preliminary data ... in the brain. Treatments for ischemic stroke currently include delivering clot-busting drugs ... The third-leading cause of death in the U.S., stroke is called a brain attack because blood flow and ...

New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation

... and convenient treatment for the prevention of stroke in patients with non-valvular ... H.S., Nakayama, H, Reith, J. et. al. Acute stroke with atrial fibrillation. stroke 1996;27: 1765-1769. 3. Hylek AM, et al. N ...

Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation

... will compare DU-176b with warfarin in preventing stroke and systemic embolic events (SEE) in patients ... option for the prevention of clotting or stroke in patients with atrial fibrillation other than ... H.S., Nakayama, H, Reith, J. et. al. Acute stroke with atrial ....

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... studies on screening methods that help determine stroke risk in children with sickle cell disease, as ... "Finding innovative ways to detect the risk of stroke in children like Alexandria is essential to ... Screening Program Is Effective in Preventing stroke in Children With Sickle Cell Disease [Abstract ...

Portable CT Increases Chance of Stroke Survival and Recovery

... room can significantly increase the number of stroke victims who receive a potentially life-saving ... facilitated more rapid assessment of acute stroke patients and is anticipated to increase the ... National Institute of Neurological Disorders and stroke ...

Do You Know You're Having a Stroke?

... -- A Mayo Clinic study shows a majority of stroke patients don't think they're having a stroke -- and as a result -- delay seeking treatment ... emergency department with either acute ischemic stroke or a transient ischemic attack (TIA), a temporary ...

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study

... -- the combined risk of heart attack, stroke or CV death was reduced by nearly half (47%, ... was cut by more than half (54%, p -- risk of stroke was cut by nearly half (48%, p=0.002). -- total ... 50% reduction in the risk of heart attack and stroke in a population of patients who had elevated ...

Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke

... vs. 2.3%, p<0.0001), 50% higher for non-fatal stroke (2.4% vs 1.6%, p<0.0001), and nearly 50% higher ... combined endpoint of CV death, heart attack and stroke and/or hospitalization for ... experienced CV death, non-fatal MI or non-fatal stroke within a year. Among the findings, the ...

Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data

... after more than four years of hard work on our stroke program, we are rapidly approaching these two ... conference calls. About the Current Viprinex stroke Trials The ongoing Phase 3 clinical studies are ... stroke when initiated within six hours of stroke onset. The studies are randomized, double-blind, ...

ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin

... -- - Results Presented at World stroke Congress in Vienna ThromboGenics NV (Euronext ... when administered intravenously to acute stroke patients. The trial showed that microplasmin was ... Late-Breaking Clinical Trial session at the World stroke Congress. The MITI IV (Microplasmin In ...

Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials

... The data, presented today at the 6th World stroke Conference in Vienna, Austria, are from a ... up to six hours after the onset of stroke symptoms, significantly expanding the number ... currently approved drug for the treatment of stroke in the U.S. Viprinex (ancrod) is a novel ...

Concentric Medical to Sponsor Randomized Trial

... trial of Endovascular TReatment of acute Ischemic stroke Versus mEdical management). The trial, which will ... approach by all clinicians involved in the stroke care chain. Despite a large body of clinical data ... is still only used in a very small percentage of stroke cases today," said Maria Sainz, CEO of Concentric ...

Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation

... as compared to placebo. The ATHENA stroke post-hoc analysis on non-pre-specified ... showed that Multaq(R) decreased the risk of stroke (ischemic or haemorrhagic) compared to placebo by 34% (46 vs 70 stroke events respectively; p=0.027) in atrial ...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

... of cardiovascular death, heart attack or stroke by 19 percent, with an increased risk of major ... death, non-fatal heart attack and non-fatal stroke during a median period of at least 12 months ... Organization. The Atlas of Heart Disease and stroke - Deaths from Coronary Heart Disease. ....

Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation

... Multaq(R) (Dronedarone) Decreased the Risk of stroke by 34% in Patients With Atrial Fibrillation or ... as compared to placebo. The ATHENA stroke post-hoc analysis on non-pre-specified ... showed that Multaq(R) decreased the risk of stroke (ischemic or haemorrhagic) compared to placebo by ...

Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue

... discovered at BRNI -- administered 24 hours after stroke can rescue and repair brain tissue. These findings are markedly advanced compared to current stroke treatments that must be administered within three ... repairs the brain and improves memory. "Today's stroke patient has precious minutes to receive care ...

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

... of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure ... of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure. ... cardiovascular death, myocardial infarction and stroke in high-risk cardiovascular patients by 13% ...

Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

... death, non-fatal heart attack and non-fatal stroke was reduced by 30 percent in diabetes patients ... death, non-fatal heart attack and non-fatal stroke with prasugrel, 37 percent for insulin treated ... endpoint of cardiovascular death, heart attack or stroke by 19 percent, with an increased risk of major ...

Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

... of combined endpoint of recurrent heart attack, stroke or cardiovascular death after first event than ... event (composite endpoint of heart attack, stroke or cardiovascular death) than those who took ... death, non-fatal heart attacks or non-fatal stroke by 19 percent more than clopidogrel ...

Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials

... (ancrod) for the treatment of acute ischemic stroke has reached the level of patients necessary to ... is safe and effective for treating acute ischemic stroke when given within six hours of stroke onset. "We are very pleased to have reached the ...

Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women

... of alternative anticoagulants in preventing stroke and valve thrombosis. For other women taking VKAs ... since the previous guideline. Arterial ischemic stroke (AIS), usually caused by embolism or thrombosis, ... are markedly different than those in adult stroke and up to 15% of children with AIS have no ...

FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel

... the risk of cardiovascular death, heart attack or stroke in ACS patients who are to be medically managed ... (1) American Heart Association. Heart Disease and stroke Statistics - 2008 Update. Dallas, TX. American ... (2) American Heart Association. Heart Disease and stroke Statistics - 2008 Update. Dallas, TX. American ...

Stroke Study Reveals a Key Target For Improving Treatment

... about how those problems might be overcome, if a stroke victim first takes a drug currently used to treat ... findings -- made in mice -- to the treatment of stroke victims everywhere. But the LICR-Karolinska ... even if tPA wasn't given until five hours after a stroke began. The new paper details a series of ...

Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms

... a patient can sustain a devastating, even lethal, stroke as blood floods the brain tissue, said Dr. ... center a two-year certification as a primary stroke center. Certification is given for "exceptional efforts to foster better outcomes for stroke care," according to the Joint Commission. ...

PRoFESS(R) Results Announced at XVII European Stroke Conference

... largest clinical research study for secondary stroke prevention -- were presented today at the XVII European stroke Conference in Nice, France. In the study, recurrent stroke event rates for Aggrenox(R) and clopidogrel were ...

Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference

... ) reported for the first time at the European stroke Conference detailed analyses supporting the ... more likely to be successful in treating ischemic stroke than previous Phase 3 clinical trials conducted ... the prior North American and European Phase 3 stroke trials of Viprinex involving more than ...